glp-1 pregnancy risk Preconception receptor agonist use may reduce risks Glucagon-like peptide-1 receptor agonist use
Description
Holst's clinical trials, patients with type 2 diabetes were treated with GLP-1-based therapies
Wiers Neuroscientist and psychiatrist Dr
Maintenance (week 17 onward, 2.4 mg): the dose carried through the 68-week trial endpoint
This study also has several limitations
